| Characteristic | Placebo (N = 11) | 5 mg/kg PRO 140 (N = 10) | 10 mg/kg PRO 140 (N = 10) | All subjects (N = 31) |
| Age (yrs) | 40.2 (22.3 to 56.6) | 44.7 (28.0 to 55.9) | 45.3 (25.9 to 57.2) | 42.7 (22.3 to 57.2) |
| Sex (no. male/no. female) | 9/2 | 10/0 | 10/0 | 29/2 |
| Race (no. black/no. white/ no. other) | 4/7/0 | 2/8/0 | 3/6/1 | 9/21/1 |
| Weight (kg) | 82.4 (65.7 to 101.5) | 79.1 (62.2 to 126.0) | 82.3 (67.5 to 95.0) | 81.4 (62.2 to 126.0) |
| CD4+ cell count, cells/µL | 414.5 (316 to 738) | 389 (321 to 519) | 368 (264 to 595) | 382 (264 to 738) |
| HIV‐1 RNA level, log10 copies/mL | 4.52 (3.76 to 5.12) | 4.58 (3.88 to 4.75) | 4.63 (3.79 to 5.53) | 4.52 (3.76 to 5.53) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.